Abstract
Actinomycetes family including Streptomyces species have been a major source for the discovery of novel natural products (NPs) in the last several decades thanks to their structural novelty, diversity and complexity. Moreover, recent genome mining approach has provided an attractive tool to screen potentially valuable NP biosynthetic gene clusters (BGCs) present in the actinomycetes genomes. Since many of these NP BGCs are silent or cryptic in the original actinomycetes, various techniques have been employed to activate these NP BGCs. Heterologous expression of BGCs has become a useful strategy to produce, reactivate, improve, and modify the pathways of NPs present at minute quantities in the original actinomycetes isolates. However, cloning and efficient overexpression of an entire NP BGC, often as large as over 100 kb, remain challenging due to the ineffectiveness of current genetic systems in manipulating large NP BGCs. This mini review describes examples of actinomycetes NP production through BGC heterologous expression systems as well as recent strategies specialized for the large-sized NP BGCs in Streptomyces heterologous hosts.
Introduction
Natural products (NPs) and their derivatives lead a huge pharmaceutical market share comprising 61% of anticancer drugs and 49% of anti-infection medicine in the past 30 years (Newman and Cragg, 2012). Especially, actinomycetes NPs are a major resource for drug discovery and development, mainly due to their structural novelty, diversity, and complexity (Donadio et al., 2007). Isolation and characterization of NP biosynthetic gene clusters (BGCs) have further accelerated our understanding of their molecular biosynthetic mechanisms, leading to the rational redesign of novel NPs through BGC manipulation (Fischer et al., 2003; Castro et al., 2015).
Some of these potentially valuable BGCs are, however, derived from non-culturable meta-genomes or genetically recalcitrant microorganisms. Moreover, many of these BGCs are expressed poorly or not at all under laboratory culture conditions, which makes it challenging to characterize the target NPs (Galm and Shen, 2006). Since efficient expression of actinomycetes NP BGCs present a major bottleneck for novel NP discovery, various cryptic BGC awakening strategies such as regulatory genes control, ribosome engineering, co-culture fermentation, and heterologous expression have been pursued for NP development (Tang et al., 2000; Flinspach et al., 2014; Martinez-Burgo et al., 2014; Miyamoto et al., 2014).
A traditional method for BGC cloning involves cosmid library construction by partial digestion or random shearing of chromosomal DNA. A typical size of NP BGC is usually larger than 20 kb (sometimes over 100 kb), and a cosmid vector system can only accept a relatively small BGC (up to 40 kb) or only a part of a large BGC. Therefore, cloning and efficient overexpression of an entire BGC still remains challenging due to the ineffectiveness of current host cells including the genetic and metabolic characteristics in manipulating large BGCs for heterologous expression. This mini review summarizes the list of the actinomycetes NP BGCs that have been successfully cloned and expressed in Streptomyces heterologous hosts (Table 1). In addition, three cloning and heterologous expression systems, which are quite suitable for large NP BGCs, such as transformation-associated recombination (TAR) system, integrase-mediated recombination (IR) system, and plasmid Streptomyces bacterial artificial chromosome (pSBAC) system are introduced (Figure 1).
Table 1
| NP name (Class) | Original host | BGC size (kb) | Expression method | Heterologous host | WT titer (mg/L) | HH titter (mg/L) | References |
|---|---|---|---|---|---|---|---|
| A201A (Nucleoside) | Sacchaothrix mutabilis subsp. Capreolus | 34 | PAC Integrative | S. coelicolor S. lividans | 12 | 8 | Saugar et al., 2016 |
| A54145 (NRPS) | S. fradiae NRRL 18160 | ~60 | BAC Integrative | S. ambofaciens S. roseosporus | NR | 100 ~ 385 | Alexander et al., 2010 |
| Actinorhodin (PKS II) | S. coelicolor M145 | 33 | LLHR Integrative | Streptomyces | NR | NR | Chen and Qin, 2011 |
| Amicetin (NRPS) | S. vinaceusdrappus NRRL 2363 | 37.3 | Cosmid Replicative | S. lividans | NR | NR | Zhang et al., 2012 |
| Ammosamides A-C (Alkaloid) | S. sp. CNR-698 | 35 | TAR Integrative | S. coelicolor | 4 ~ 6 | 17 | Jordan and Moore, 2016 |
| Anthracimycin (PKS I) | S. sp. T676 | 53.2 | PAC Integrative | S. coelicolor | NR | 8.6 ~ 13.8 | Alt and Wilkinson, 2015 |
| Aristeromycin (Nucleoside) | S. citricolor | 37.5 | Cosmid Replicative | S. albus | NR | ND | Kudo et al., 2016 |
| Aureothin (PKS I) | S. thioluteus HKI-227 | 27 | Cosmid Integrative | S. lividans | NR | NR | He and Hertweck, 2003 |
| Barbamide (PKS-NRPS) | Moorea producens | 26 | LCHR Replicative | S. venezuelae | NR | ND* | Kim et al., 2012 |
| Bernimamycin (Thiopeptide) | S. bernensis UC5144 | 12.9 | LLHR Integrative | S. lividans S. venezuelae | NR | NR | Malcolmson et al., 2013 |
| Blasticidin S (Nucleoside) | S. griseochromogenes | 20 | Cosmid Replicative | S. lividans | NR | NR | Cone et al., 2003 |
| Cacibiocin (Aminocoumarin) | Catenulispora acidiphila | 20 | LLHR Integrative | S. coelicolor | 4.9 | 60 | Zettler et al., 2014 |
| Caerulomycin (PKS-NRPS) | Actinoalloteichus cyanogriseus WH1-2216-6 | 44.6 | Cosmid Replicative | S. coelicolor | NR | NR | Zhu et al., 2012 |
| Cephamycin C (NRPS) | S. clavuligerus ATCC 27064 | 35.6 | Cosmid Integrative | S. flavogriseus S. coelicoor S. albus | 3640 | 8 ~ 300# | Martinez-Burgo et al., 2014 |
| Chalcomycin (PKS I) | S. bikiniensis | 80 | LLHR Integrative | S. fradiae | NR | NR | Ward et al., 2004 |
| Chaxamycin (PKS I) | S. leeuwenhoekii | 80.2 | PAC Integrative | S. coelicolor | NR | NR | Castro et al., 2015 |
| Chloramphenicol (PKS-NRPS) | S. venezuelae ATCC10712 | NR | Cosmid Integrative | S. coelicolor | NR | 1.6 ~ 26.23 | Gomez-Escribano and Bibb, 2011 |
| Chlorizidine A (PKS I) | S. sp. CNH-287 | 42.4 | Fosmid Integrative | S. coelicolor | NR | NR | Mantovani and Moore, 2013 |
| Chrysomycin (PKS II) | S. albaduncus AD0819 | 34.65 | Cosmid Replicative | S. lividans | NR | ND | Kharel et al., 2010 |
| Clavulanic acid (β-lactam) | S. clavuligerus ATCC27064 | 20 | Cosmid Integrative | S. flavogriseus S. coelicolor | 164.50 | 0.6 | Alvarez-Alvarez et al., 2013 |
| Complestatin (Glycopeptide) | S. chartreusis AN1542 | 54.5 | LLHR Integrative | S. lividans | 5.57 | 0.24 | Park et al., 2016 |
| Congocidine (NRPS) | S. ambofaciens ATCC23877 | NR | Cosmid Integrative | S. coelicolor | NR | NR | Gomez-Escribano and Bibb, 2011 |
| Coumermycin A1 (Aminocoumarin) | S. rishiriensis DSM40489 | 38.6 | Cosmid Integrative | S. coelicolor | 0.002 ~ 0.005 | 0.01 | Wolpert et al., 2008 |
| Cremeonycin (Diazoquinone) | S. cremeus NRRL3241 | 18 | BAC Integrative | S. lividans | NR | NR | Waldman et al., 2015 |
| Cyclothiazomycin (Thiopeptide) | S. hygroscopicus 10-22 | 22.7 | LLHR Integrative | S. lividans | NR | NR | Wang et al., 2010 |
| Daptomycin (NRPS) | S. roseosporus NRRL 11379 | 128 | BAC Integrative | S. lividans | 900 | 18 | Miao et al., 2005 |
| Desotamide (NRPS) | S. scopuliridis SCSIO | 39 | Cosmid Integrative | S. coelicolor | NR | ND* | Li et al., 2015 |
| Epothilone (PKS-NRPS) | Sorangium cellulosum SHP44 | 56 | LLHR Replicative & Integrative | S. coelicolor | 0.05 ~ 0.1 | 20 | Tang et al., 2000 |
| FK506 (PKS I) | S. sp. KCCM11116P | 120 | LCHR Integrative | S. albus | NR | NR | Chen et al., 2014 |
| S. tsukubaensis | 83.5 | PAC Integrative | S. coelicolor | 1.20 | 5.50 | Jones et al., 2013 | |
| Flustatin (PKS II) | Micromonospora SCSIO N160 | 40 | Cosmid Replicative | S. coelicolor | NR | NR | Yang et al., 2015 |
| Fostriecin PKS (PKS I) | S. pulveraceus ATCC31906 | 48.6 | LLHR Replicative & Integrative | S. coelicolor S. lividans | NR | ND | Su et al., 2015 |
| Galbonolide B (PKS I) | S. sp. L235 | 12.1 | LLHR Integrative | S. coelicolor | NR | NR† | Liu et al., 2015 |
| GE2270 (Thiopeptide) | Planobispora rosea ATCC53733 | 21.4 | LLHR Integrative | S. coelicolor | NR | 0.08 | Flinspach et al., 2014 |
| GE37468 (Thiazolyl peptide) | S. ATCC 55365 | 17.1 | LLHR Integrative | S. lividans | 5 ~ 7 | 2 ~ 3 | Young and Walsh, 2011 |
| Gilvocarcin V (PKS II) | S. griseoflavus Gö 3592 | 32.9 | Cosmid Replicative | S. lividans | 20 ~ 30 | NR | Fischer et al., 2003 |
| Goadsporin (Azole) | S. sp. TP-A0584 | 14 | LLHR Integrative | S. lividans | 126.3 | 342.7 | Haginaka et al., 2014 |
| Gougerotin (Nucleoside) | S. graminearus | 28.7 | LCHR Integrative | S. coelicolor | NR | NR | Niu et al., 2013 |
| Granaticin (PKS II) | S. violaceoruber Tü22 | 39 | Cosmid Replicative | S. coelicolor | NR | NR | Ichinose et al., 1998 |
| Grecocycline (PKS II) | S. sp. Acta 1362 | 36 | TAR Integrative | S. albus | NR | ND* | Bilyk et al., 2016 |
| Grincamycin (PKS II) | S. lusitanus SCSIO LR32 | 37 | LCHR Integrative | S. coelicolor | NR | ND* | Zhang et al., 2013 |
| Holomycin (NRPS) | S. clavuligerus ATCC27064 | 24 | LLHR Integrative | S. coelicolor | NR | NR | Robles-Reglero et al., 2013 |
| Kanamycin (Aminoglycoside) | S. kanamyceticus ATCC12853 | 32 | Cosmid Replicative | S. venezuelae | 1.80 | 0.50 | Thapa et al., 2007 |
| Kinamycin (PKS II) | S. murayamaensis | 40 | Cosmid Replicative | S. lividans | NR | ND | Gould et al., 1998 |
| Lincomycin (Lincosamide) | S. lincolnensis ATCC25466 | 35 | Cosmid Integrative | S. coelicolor | 50.1 | 0.66 ~ 1.49 | Koberska et al., 2008 |
| Lyngbyatoxin A (NRPS) | Moorea products | 11.3 | LLHR Replicative | S. coelicolor | NR | NR | Jones et al., 2012 |
| Lysolipin (PKS II) | S. tendae Tü 4042 | 43.2 | Cosmid Replicative | S. albus | NR | NR | Lopez et al., 2010 |
| Macrotetrolide (PKS II) | S. griseus DSM40695 | 25 | LLHR Integrative | S. lividans | 40 | 10 | Kwon et al., 2001 |
| Marineosin (Oligopyrrole) | S. sp. CNQ-617 | 32 | Cosmid Integrative | S. venezuelae | 0.5 | 5 | Salem et al., 2014 |
| Medermycin (PKS II) | S. sp. AM7161 | 30 | LLHR Integrative | S. coelicolor S. lividans | NR | NR | Ichinose et al., 2003 |
| S. sp. K73 | 36.2 | Cosmid Replicative | S. coelicolor | NR | NR | Ichinose et al., 2003 | |
| Mensacarcin (PKS II) | S. bottropensis | 40 | Cosmid Integrative | S. albus | NR | ND* | Yan et al., 2012 |
| Meridamycin (PKS-NRPS) | S. sp. NRRL 30748 | 90 | pSBAC Integrative | S. lividans | NR | 0.1# | Liu et al., 2009 |
| Merochlorin A-D (PKS-terpenoid) | S. sp. CNH-189 | 57.6 | Fosmid Integrative | S. coelicolor | 10.0 | NR | Kaysser et al., 2012 |
| Mycosperine | Actinosynnema mirum DSM43827 | 6.3 | LLHR Integrative | S. avermitilis | NR | NR# | Miyamoto et al., 2014 |
| Naphthocyclinone (PKS II) | S. arenae DSM40737 | 12 | Cosmid Replicative | S. coelicolor | NR | NR | Brunker et al., 1999 |
| Nataxazole (PKS I) | S. sp. Tü6176 | 44.1 | TAR Integrative | S. lividans | NR | ND* | Cano-Prieto et al., 2015 |
| Neocarzilin (PKS I) | S. carzinostaticus var. F-41 | 33 | Cosmid Integrative | S. lividans | NR | NR | Otsuka et al., 2004 |
| Nogalamycin (PKS II) | S. nogalater | 20 | Cosmid Replicative | S. lividans | NR | NR | Ylihonko et al., 1996 |
| 29 | LLHR Replicative | S. lividans S. galilaeus S. peucetius | NR | NR | Torkkell et al., 2001 | ||
| Novobiocin (Aminocoumarin) | S. spheroides | 25.6 | Cosmid Replicative | S. lividans | NR | NR† | Steffensky et al., 2000 |
| Oleandomycin (PKS I) | S. antibiticus | 65 | LLHR Replicative | S. lividans | NR | NR† | Shah et al., 2000 |
| Oxytetracycline (PKS II) | S. rimosus M4018 | 29 | Cosmid Integrative | S. venezuelae | 75 | 431 | Yin et al., 2016 |
| S. rimosus | 34 | Cosmid Replicative | S. lividans | NR | 20 | Binnie et al., 1989 | |
| Phosphinothricin (NRPS) | S. viridochromogenes DSM 40736 | 40 | Fosmid Integrative | S. lividans | NR | NR | Blodgett et al., 2005 |
| Puromycin (Nucleoside) | S. alboniger | 13 | Cosmid Replicative | S. lividans S. griseofuscus | 150.00 | 4 ~ 15 | Lacalle et al., 1992 |
| R1128 (PKS II) | S. sp. R1128 | 17 | Cosmid Replicative | S. lividans | NR | 1.00 | Marti et al., 2000 |
| Ravidomycin PKS II | S. ravidus | 33.28 | Cosmid Replicative | S. lividans | NR | NR | Kharel et al., 2010 |
| Rebeccamycin (Indolocarbazole) | Saccharothrix aerocolonigenes ATCC 39243 | 25.6 | Cosmid Replicative | S. albus | NR | NR | Sanchez et al., 2002 |
| Resorcinomycin | Streptorerticilium roseoverticillatum | 11 | LLHR Replicative | S. lividans | NR | ND* | Ooya et al., 2015 |
| Rimosamide (NRPS-PKS) | S. rimosus NRRL B-2659 | 30.5 | Fosmid Integrative | S. lividans | NR | NR | McClure et al., 2016 |
| Rishirilide A (PKS II) | S. bottropensis | 50 | Cosmid Integrative | S. albus, S. lividans | NR | NR | Yan et al., 2012 |
| Salinomycin (PKS I) | S. albus DSM41398 | 106 | LLHR Integrative | S. coelicolor | NR | NR | Yin et al., 2015 |
| Sparsomycin (NRPS) | S. sparsogenes | 30 | TAR Integrative | S. lividans | NR | NR | Rui et al., 2015 |
| Staurosporine (Indolocarbazole) | S. sanyensis FMA | 34.6 | Cosmid Integrative | S. coelicolor | NR | NR | Li T. et al., 2013 |
| S. sp. TP-A0274 | 20 | Cosmid Integrative | S. lividans | 10.5 | 2.6 | Onaka et al., 2002 | |
| Streptocolin (Lanthipeptide) | S. colimus Tü365 | 6 | Cosmid Integrative | S. coelicolor | NR | 5.4 ~ 110 | Iftime et al., 2015 |
| Streptothricin (NRPS) | S. sp. TP-A0356 | 41 | Cosmid Replicative | S. coelicolor | NR | NR | Li J. et al., 2013 |
| Tautomycetin (PKS I) | S. sp. CK4412 | 80 | pSBAC Integrative | S. coelicolor S. lividans | 3.10 | 3.91 ~ 4.05 | Nah et al., 2015 |
| Tetracenomycin C (PKS II) | S. glaucescens | 24 | LLHR Replicative | S. lividans | NR | NR | Motamedi and Hutchinson, 1987 |
| Tetrangulol (PKS II) | S. sp. WP4669 S. rimosus NRRL3016 | 40 | Cosmid Replicative | S. lividans | NR | NR | Hong et al., 1997 |
| Thioriridamide (Ribosomal peptide) | S. olivoriridis NA05001 | 14.5 | LLHR Replicative | S. lividans | NR | NR | Izawa et al., 2013 |
| 70 | BAC Integrative | S. avermitilis | NR | 2.5 | Izumikawa et al., 2015 | ||
| TP-1161 (Thiopeptide) | Nocardiopsis sp. TFS65-07 | 16 | Cosmid Replicative | S. coelicolor | NR | ND | Engelhardt et al., 2010 |
| Undecylprodigiosin (NRPS) | S. coelicolor M145 | 38 | LLHR Replicative | S. parvulus | NR | NR | Malpartida et al., 1990 |
| Validamycin (Pseudosaccharide) | S. hygroscopicus var. limoneus KTCC 1715 | 37 | Cosmid Replicative | S. lividans S. albus | NR | NR | Singh et al., 2006 |
| Venemycin (PKS I) | S. venezuelae | 29.5 | Cosmid Integrative | S. coelicolor | NR | ND | Thanapipatsiri et al., 2016 |
| Versipelostatin (PKS I) | S. versipellis 4083 | 108 | BAC Integrative | S. albus | 1.5 | 21.0 | Hashimoto et al., 2015 |
| YM-216391 (NRPS) | S. nobilis | <40 | Cosmid Replicative | S. lividans | NR | 0.18 | Jian et al., 2012 |
Heterologous expression of NP BGCs.
PKS, polyketide synthase; NRPS, non-ribosomal peptide synthase; S, Streptomyces; sp, species; TAR, transformation-associated recombination; PAC, phage P1 artificial chromosome; BAC, bacterial artificial chromosome; LLHR, linear-plus-linear homologous recombination; LCHR, linear-plus-circular homologous recombination; NR, not reported (but produced); ND, not detected (not produced); WT, wild type; HH, heterologous host;
intermediate produced only;
expressed part of gene cluster;
produced by gene cluster modification (e.g., Promoter substitution).
Figure 1
Traditional method for heterologous expression of NP BGCs
We summarized about 90 actinomycetes NP BGCs that have been successfully expressed in Streptomyces heterologous hosts from the last several decades (Table 1). Relatively small BGCs encoding Type II polyketide were first to be isolated at the beginning of heterologous expression research. Many of the listed BGCs (about 83%) were isolated by cosmid/fosmid library construction and some of these BGCs were cloned into replicative or integrative vector by linear-plus-linear (recombination between two linear DNAs) or linear-plus-circular (recombination between linear and replicating circular DNA) homologous recombination. Approximately 60% of BGCs were integrated into the heterologous host chromosome and only 37% of BGCs existed in the heterologous host via replicative plasmid. Cosmid vectors such as pOJ446 and SuperCos1 were used to be replicative or integrative in the heterologous host, so the production level of the heterologously expressed NP BGC varied significantly. Some BGCs were isolated with two different vector systems, followed by heterologous expression via both integrative and replicative systems. For example, the epothilone BGC was expressed by both pSET152-based integration vector and SCP2*-based replication vectors, so that its expression level was increased from 0.1 mg/L in the original Sorangium cellulosum system to 20 mg/L in the epothilone BGC-expressing Streptomyces host (Tang et al., 2000). S. coelicolor and S. lividans were two major strains for heterologous expression, thanks to their well-characterized genetic and biochemical properties. About 12% BGCs were expressed in another popular heterologous host, S. albus, which has fast growth and an efficient genetic system (Zaburannyi et al., 2014). Comparing with the original NP producing strains, approximately 14% of NPs had a higher expression level and 12% lower when they were expressed in the heterologous hosts. When bernimamycin BGC was heterologously expressed both in S. lividans and S. venezuelae, its production yield was increased 2.4-fold in S. lividans with no production in S. venezuelae (Malcolmson et al., 2013).
Cloning systems of large NP BGCs for heterologous expression in Streptomyces
TAR system
The TAR system takes advantage of the natural in vivo homologous recombination of Saccharomyces cerevisiae (Larionov et al., 1994). It has also been applied to capture and express large biosynthetic gene clusters from environmental DNA samples (Feng et al., 2010; Kim et al., 2010). Yamanaka and colleagues designed TAR cloning vector, pCAP01, which consists of three elements, one from each of yeast, E. coli, and actinobacteria (Yamanaka et al., 2014). The target BGC can be directly captured and manipulated in yeast background, and the captured BGC can be shuttled between E. coli and actinobacteria species. It also has a pUC ori that could stably carry an over 50 kb insert in E. coli hosts. The pCAP01 vector contains oriT and attP-int that can transfer the target BGC by conjugation, and the DNA stability can be maintained by insertion into heterologous host chromosomes. To generate a capturing vector, both flanking homologous arms of the target BGC were PCR-amplified and cloned into the pCAP01. The linearized capturing vector and the restriction enzyme digested genomic DNA were co-transformed into yeast, then the target BGC was captured by yeast recombination activities (Figure 1A). The marinopyrrole BGC (30 kb) and the taromycin A BGC (67 kb) were captured by this TAR system, and functionally expressed in Streptomyces coelicolor (Yamanaka et al., 2014).
IR system
Most cloning systems to clone a large DNA fragment directly from bacterial genome are based on different site-specific recombination systems that consist of a specialized recombinase and its target sites. The IR system is based on ΦBT1 integrase-mediated site-specific recombination and simultaneous Streptomyces genome engineering (Du et al., 2015). The actinorhodin BGC, the napsamycin BGC and the daptomycin BGC were successfully isolated by the IR system (Du et al., 2015). pUC119-based suicide vector and pKC1139 carrying mutated attP or attB, respectively, and an integrative plasmid containing the ΦBT1 integrase gene were used for the system (Figure 1B). The pUC119-based plasmid carrying mutated attB and a homologous region to 5′ end of the target BGC was introduced into the chromosome by single crossover. The pKC1139 carrying mutated attP and a homologous region to 3′ end of the BGC was transferred and integrated into chromosome by conjugation and single crossover through cultivation at high temperature above 34°C. Expression of ΦBT1 integrase leads to excision of the pKC1139 containing the target BGC. The pKC1139 containing BGC from original producing Streptomyces was extracted and transferred into E. coli for recovery. The IR system was only expressed in parental strain not heterologous host, but it was presumed to be transferred and maintained by replication in heterologous host (Du et al., 2015).
pSBAC vector system
In the early 1990s, Bacterial Artificial Chromosomes (BAC) was reported to carry inserts approaching 200 kb in length emerged (Shizuya et al., 1992). Various BAC vectors have been used extensively for construction of DNA libraries to facilitate physical genomic mapping and DNA sequencing efforts (Sosio et al., 2000; Martinez et al., 2004; Fuji et al., 2014; Varshney et al., 2014). Several E. coli-Streptomyces shuttle BAC vectors have been developed to carry the large-sized NP BGCs such as pStreptoBAC V and pSBAC (Miao et al., 2005; Liu et al., 2009). The utility of pSBAC was demonstrated through the precise cloning and heterologous expression of the tautomycetin BGC and the pikromycin BGC of the type I PKS biosynthetic pathway, as well as the meridamycin BGC of the PKS-NRPS hybrid biosynthetic pathways (Liu et al., 2009; Nah et al., 2015). Unique restriction enzyme recognition sites naturally existing or artificially inserted into both flanking regions of the entire BGC were used for capturing the BGCs. The pSBAC vector was also inserted within the unique restriction enzyme site by homologous recombination. And then the entire target BGC was captured in a single pSBAC through straightforward single restriction enzyme digestion and self-ligation (Figure 1C). The pSBAC contains two replication origins, ori2 and oriV, for DNA stability in E. coli, and oriT and ΦC31 attP-int for BGC integration into the surrogate host chromosome through intergenic conjugation. The recombinant pSBAC containing the large BGCs of varied length from 40 kb to over 100 kb have been successfully cloned and conjugated from E. coli to S. coelicolor and S. lividans (Liu et al., 2009; Nah et al., 2015), implying that the pSBAC system seems to be the most suitable for large BGC cloning comparing with TAR and IR systems.
Recently, a new cloning method named CATCH (Cas9-Assisted Targeting of Chromosome) based on the in vitro application of RNA-guided Cas9 nuclease was developed (Jiang and Zhu, 2016). The Cas9 nuclease cleaves target DNA in vitro from intact bacterial chromosomes embedded in agarose plugs, which can be subsequently ligated with cloning vector through Gibson assembly. Jiang and colleagues cloned the 36-kb jadomycin BGC from S. venezuelae and the 32-kb chlortetracycline BGC from S. aureofaciens by CATCH (Jiang et al., 2015).
Streptomyces heterologous expression of NP BGCs
The Streptomyces genus is suitable for heterologous expression of large NP BGCs due to its intrinsic ability to produce various valuable secondary metabolites. Well-studied Streptomyces strains such as S. coelicolor, S. lividans, and S. albus have been mainly used as heterologous expression surrogate hosts (Table 1). The regulatory networks of secondary metabolite production have been well characterized in these strains, and thus several NP high-level producing strains have been constructed (Baltz, 2010; Gomez-Escribano and Bibb, 2011). In addition, some of these Streptomyces host genomes have been further engineered to eliminate precursor-competing biosynthetic BGCs, so that the extra precursors such as malonyl-CoA and acetyl-CoA could be funneled into the target polyketide NP biosynthesis (Gomez-Escribano and Bibb, 2011).
As shown in Table 1, most of the heterologously expressed NPs were detected as a final product, but some were detected as an intermediate due to their partial BGC expression. The NP production yield was similar to or slightly lower than that in WT. To increase the production level in heterologous hosts, it was devised to substitute with strong promoters or to increase the copy number of BGCs (Montiel et al., 2015; Nah et al., 2015). In case of pSBAC system, the tautomycetin production yield in the heterologous hosts was similar to that in the original producing strain. The selection marker on the tautomycetin BGC was changed and re-introduced into the heterologous host by tandem repeat, resulting in further yield increase from 3.05 to 13.31 mg/L in comparison with the heterologous host harboring only single copy of tautomycetin BGC. The heterologous host harboring tandem copies of tautomycetin BGC was proved to stably maintain two BGCs in the presence of appropriate antibiotic selection (Nah et al., 2015).
Meanwhile, the TAR system used yeast homologous recombination-based promoter engineering for the activation of silent natural product BGCs (Montiel et al., 2015). Bi-directional promoter cassettes were generated by PCR amplification of varied yeast selectable markers, which contains promoter-insulator-RBS combinations, and they were co-transformed with the cosmid or BAC clone harboring the target BGC into yeast. The rebeccamycin BGC was used as a model BGC. The promoter-replaced rebeccamycin BGC was transferred into S. albus by conjugation, and the production of rebeccamycin was examined in the heterologous host (Montiel et al., 2015). Using the TAR-based promoter engineering strategy, multiple promoter cassettes could be inserted simultaneously into the target BGC, thereby expediting the re-engineering process. The TAR-based promoter engineering strategy was also used to capture the silent tetarimycin BGC and the silent, cryptic pseudogene-containing, environmental DNA-derived lazarimide BGC (Montiel et al., 2015).
In conclusion, Streptomyces heterologous expression systems have been proved to be a very attractive strategy to awaken cryptic NP BGCs, and could also be applied to overexpression of a variety of large NP BGCs in actinomycetes.
Statements
Author contributions
HN, SK, SC, and EK planned, outlined, and revised the manuscript. HN, HP, and EK wrote and revised the manuscript.
Acknowledgments
This research was supported by “National Research Foundation of Korea (NRF)” (Project No. NRF-2014R1A2A1A11052236 & NRF-2016K2A9A2A10005545).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AlexanderD. C.RockJ.HeX.BrianP.MiaoV.BaltzR. H. (2010). Development of a genetic system for combinatorial biosynthesis of lipopeptides in Streptomyces fradiae and heterologous expression of the A54145 biosynthesis gene cluster. Appl. Environ. Microbiol.76, 6877–6887. 10.1128/AEM.01248-10
2
AltS.WilkinsonB. (2015). Biosynthesis of the novel macrolide antibiotic anthracimycin. ACS Chem. Biol.10, 2468–2479. 10.1021/acschembio.5b00525
3
Alvarez-AlvarezR.Martinez-BurgoY.Perez-RedondoR.BranaA. F.MartinJ. F.LirasP. (2013). Expression of the endogenous and heterologous clavulanic acid cluster in Streptomyces flavogriseus: why a silent cluster is sleeping. Appl. Microbiol. Biotechnol.97, 9451–9463. 10.1007/s00253-013-5148-7
4
BaltzR. H. (2010). Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters. J. Ind. Microbiol. Biotechnol.37, 759–772. 10.1007/s10295-010-0730-9
5
BilykO.SekurovaO. N.ZotchevS. B.LuzhetskyyA. (2016). Cloning and heterologous expression of the grecocycline biosynthetic gene cluster. PLoS ONE11:e0158682. 10.1371/journal.pone.0158682
6
BinnieC.WarrenM.ButlerM. J. (1989). Cloning and heterologous expression in Streptomyces lividans of Streptomyces rimosus genes involved in oxytetracycline biosynthesis. J. Bacteriol.171, 887–895. 10.1128/jb.171.2.887-895.1989
7
BlodgettJ. A.ZhangJ. K.MetcalfW. W. (2005). Molecular cloning, sequence analysis, and heterologous expression of the phosphinothricin tripeptide biosynthetic gene cluster from Streptomyces viridochromogenes DSM 40736. Antimicrob. Agents Chemother.49, 230–240. 10.1128/AAC.49.1.230-240.2005
8
BrunkerP.McKinneyK.SternerO.MinasW.BaileyJ. E. (1999). Isolation and characterization of the naphthocyclinone gene cluster from Streptomyces arenae DSM 40737 and heterologous expression of the polyketide synthase genes. Gene227, 125–135. 10.1016/S0378-1119(98)00618-0
9
Cano-PrietoC.Garcia-SalcedoR.Sanchez-HidalgoM.BranaA. F.FiedlerH. P.MendezC.et al. (2015). Genome mining of Streptomyces sp. Tu 6176: characterization of the nataxazole biosynthesis pathway. Chembiochem16, 1461–1473. 10.1002/cbic.201500153
10
CastroJ. F.RazmilicV.Gomez-EscribanoJ. P.AndrewsB.AsenjoJ. A.BibbM. J. (2015). Identification and heterologous expression of the chaxamycin biosynthesis gene cluster from Streptomyces leeuwenhoekii. Appl. Environ. Microbiol.81, 5820–5831. 10.1128/AEM.01039-15
11
ChenC.ZhaoX.JinY.ZhaoZ. K.SuhJ. W. (2014). Rapid construction of a bacterial artificial chromosomal (BAC) expression vector using designer DNA fragments. Plasmid76, 79–86. 10.1016/j.plasmid.2014.10.002
12
ChenW.QinZ. (2011). Development of a gene cloning system in a fast-growing and moderately thermophilic Streptomyces species and heterologous expression of Streptomyces antibiotic biosynthetic gene clusters. BMC Microbiol.11:243. 10.1186/1471-2180-11-243
13
ConeM. C.YinX.GrochowskiL. L.ParkerM. R.ZabriskieT. M. (2003). The blasticidin S biosynthesis gene cluster from Streptomyces griseochromogenes: sequence analysis, organization, and initial characterization. ChemBioChem4, 821–828. 10.1002/cbic.200300583
14
DonadioS.MonciardiniP.SosioM. (2007). Polyketide synthases and nonribosomal peptide synthetases: the emerging view from bacterial genomics. Nat. Prod. Rep.24, 1073–1109. 10.1039/b514050c
15
DuD.WangL.TianY.LiuH.TanH.NiuG. (2015). Genome engineering and direct cloning of antibiotic gene clusters via phage ΦBT1 integrase-mediated site-specific recombination in Streptomyces. Sci. Rep.5:8740. 10.1038/srep08740
16
EngelhardtK.DegnesK. F.ZotchevS. B. (2010). Isolation and characterization of the gene cluster for biosynthesis of the thiopeptide antibiotic TP-1161. Appl. Environ. Microbiol.76, 7093–7101. 10.1128/AEM.01442-10
17
FengZ.KimJ. H.BradyS. F. (2010). Fluostatins produced by the heterologous expression of a TAR reassembled environmental DNA derived type II PKS gene cluster. J. Am. Chem. Soc.132, 11902–11903. 10.1021/ja104550p
18
FischerC.LipataF.RohrJ. (2003). The complete gene cluster of the antitumor agent gilvocarcin V and its implication for the biosynthesis of the gilvocarcins. J. Am. Chem. Soc.125, 7818–7819. 10.1021/ja034781q
19
FlinspachK.KapitzkeC.TocchettiA.SosioM.ApelA. K. (2014). Heterologous expression of the thiopeptide antibiotic GE2270 from Planobispora rosea ATCC 53733 in Streptomyces coelicolor requires deletion of ribosomal genes from the expression construct. PLoS ONE9:e90499. 10.1371/journal.pone.0090499
20
FujiK.KoyamaT.KaiW.KubotaS.YoshidaK.OzakiA.et al. (2014). Construction of a high-coverage bacterial artificial chromosome library and comprehensive genetic linkage map of yellowtail Seriola quinqueradiata. BMC Res. Notes7:200. 10.1186/1756-0500-7-200
21
GalmU.ShenB. (2006). Expression of biosynthetic gene clusters in heterologous hosts for natural product production and combinatorial biosynthesis. Expert Opin. Drug Discov.1, 409–437. 10.1517/17460441.1.5.409
22
Gomez-EscribanoJ. P.BibbM. J. (2011). Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters. Microb. Biotechnol.4, 207–215. 10.1111/j.1751-7915.2010.00219.x
23
GouldS. J.HongS. T.CarneyJ. R. (1998). Cloning and heterologous expression of genes from the kinamycin biosynthetic pathway of Streptomyces murayamaensis. J. Antibiot. (Tokyo)51, 50–57. 10.7164/antibiotics.51.50
24
HaginakaK.AsamizuS.OzakiT.IgarashiY.FurumaiT.OnakaH. (2014). Genetic approaches to generate hyper-producing strains of goadsporin: the relationships between productivity and gene duplication in secondary metabolite biosynthesis. Biosci. Biotechnol. Biochem.78, 394–399. 10.1080/09168451.2014.885824
25
HashimotoT.HashimotoJ.TeruyaK.HiranoT.Shin-yaK.IkedaH.et al. (2015). Biosynthesis of versipelostatin: identification of an enzyme-catalyzed [4+2]-cycloaddition required for macrocyclization of spirotetronate-containing polyketides. J. Am. Chem. Soc.137, 572–575. 10.1021/ja510711x
26
HeJ.HertweckC. (2003). Iteration as programmed event during polyketide assembly; molecular analysis of the aureothin biosynthesis gene cluster. Chem. Biol.10, 1225–1232. 10.1016/j.chembiol.2003.11.009
27
HongS. T.CarneyJ. R.GouldS. J. (1997). Cloning and heterologous expression of the entire gene clusters for PD 116740 from Streptomyces strain WP 4669 and tetrangulol and tetrangomycin from Streptomyces rimosus NRRL 3016. J Bacteriol.179, 470–476. 10.1128/jb.179.2.470-476.1997
28
IchinoseK.BedfordD. J.TornusD.BechtholdA.BibbM. J.RevillW. P.et al. (1998). The granaticin biosynthetic gene cluster of Streptomyces violaceoruber Tu22: sequence analysis and expression in a heterologous host. Chem. Biol.5, 647–659. 10.1016/S1074-5521(98)90292-7
29
IchinoseK.OzawaM.ItouK.KuniedaK.EbizukaY. (2003). Cloning, sequencing and heterologous expression of the medermycin biosynthetic gene cluster of Streptomyces sp. AM-7161: towards comparative analysis of the benzoisochromanequinone gene clusters. Microbiology149, 1633–1645. 10.1099/mic.0.26310-0
30
IftimeD.JasykM.KulikA.ImhoffJ. F.StegmannE.WohllebenW.et al. (2015). Streptocollin, a Type IV lanthipeptide produced by Streptomyces collinus Tu 365. Chembiochem16, 2615–2623. 10.1002/cbic.201500377
31
IzawaM.KawasakiT.HayakawaY. (2013). Cloning and heterologous expression of the thioviridamide biosynthesis gene cluster from Streptomyces olivoviridis. Appl. Environ. Microbiol.79, 7110–7113. 10.1128/AEM.01978-13
32
IzumikawaM.KozoneI.HashimotoJ.KagayaN.TakagiM.KoiwaiH.et al. (2015). Novel thioviridamide derivative–JBIR-140: heterologous expression of the gene cluster for thioviridamide biosynthesis. J. Antibiot. (Tokyo)68, 533–536. 10.1038/ja.2015.20
33
JianX. H.PanH. X.NingT. T.ShiY. Y.ChenY. S.LiY.et al. (2012). Analysis of YM-216391 biosynthetic gene cluster and improvement of the cyclopeptide production in a heterologous host. ACS Chem. Biol.7, 646–651. 10.1021/cb200479f
34
JiangW.ZhaoX.GabrieliT.LouC.EbensteinY.ZhuT. F. (2015). Cas9-assisted targeting of chromosome segments CATCH enables one-step targeted cloning of large gene clusters. Nat. Commun.6:9101. 10.1038/ncomms9101
35
JiangW.ZhuT. F. (2016). Targeted isolation and cloning of 100-kb microbial genomic sequences by Cas9-assisted targeting of chromosome segments. Nat. Protoc.11, 960–975. 10.1038/nprot.2016.055
36
JonesA. C.GustB.KulikA.HeideL.ButtnerM. J.BibbM. J. (2013). Phage p1-derived artificial chromosomes facilitate heterologous expression of the FK506 gene cluster. PLoS ONE8:e69319. 10.1371/journal.pone.0069319
37
JonesA. C.OttilieS.EustaquioA. S.EdwardsD. J.GerwickL.MooreB. S.et al. (2012). Evaluation of Streptomyces coelicolor A3(2) as a heterologous expression host for the cyanobacterial protein kinase C activator lyngbyatoxin A. FEBS J.279, 1243–1251. 10.1111/j.1742-4658.2012.08517.x
38
JordanP. A.MooreB. S. (2016). Biosynthetic pathway connects cryptic ribosomally synthesized posttranslationally modified peptide genes with pyrroloquinoline alkaloids. Cell Chem. Biol.23, 1504–1514. 10.1016/j.chembiol.2016.10.009
39
KaysserL.BernhardtP.NamS. J.LoesgenS.RubyJ. G.Skewes-CoxP.et al. (2012). Merochlorins, A.-D., cyclic meroterpenoid antibiotics biosynthesized in divergent pathways with vanadium-dependent chloroperoxidases. J. Am. Chem. Soc.134, 11988–11991. 10.1021/ja305665f
40
KharelM. K.NyboS. E.ShepherdM. D.RohrJ. (2010). Cloning and characterization of the ravidomycin and chrysomycin biosynthetic gene clusters. Chembiochem11, 523–532. 10.1002/cbic.200900673
41
KimE. J.LeeJ. H.ChoiH.PereiraA. R.BanY. H.YooY. J.et al. (2012). Heterologous production of 4-O-demethylbarbamide, a marine cyanobacterial natural product. Org. Lett.14, 5824–5827. 10.1021/ol302575h
42
KimJ. H.FengZ.BauerJ. D.KallifidasD.CalleP. Y.BradyS. F. (2010). Cloning large natural product gene clusters from the environment: piecing environmental DNA gene clusters back together with TAR. Biopolymers93, 833–844. 10.1002/bip.21450
43
KoberskaM.KopeckyJ.OlsovskaJ.JelinkovaM.UlanovaD.ManP.et al. (2008). Sequence analysis and heterologous expression of the lincomycin biosynthetic cluster of the type strain Streptomyces lincolnensis ATCC 25466. Folia Microbiol. (Praha)53, 395–401. 10.1007/s12223-008-0060-8
44
KudoF.TsunodaT.TakashimaM.EguchiT. (2016). Five-membered cyclitol phosphate formation by a myo-inositol phosphate synthase orthologue in the biosynthesis of the carbocyclic nucleoside antibiotic aristeromycin. Chembiochem17, 2143–2148. 10.1002/cbic.201600348
45
KwonH. J.SmithW. C.XiangL.ShenB. (2001). Cloning and heterologous expression of the macrotetrolide biosynthetic gene cluster revealed a novel polyketide synthase that lacks an acyl carrier protein. J. Am. Chem. Soc.123, 3385–3386. 10.1021/ja0100827
46
LacalleR. A.TerceroJ. A.JimenezA. (1992). Cloning of the complete biosynthetic gene cluster for an aminonucleoside antibiotic, puromycin, and its regulated expression in heterologous hosts. EMBO J.11, 785–792.
47
LarionovV.KouprinaN.EldarovM.PerkinsE.PorterG.ResnickM. A. (1994). Transformation-associated recombination between diverged and homologous DNA repeats is induced by strand breaks. Yeast10, 93–104. 10.1002/yea.320100109
48
LiJ.GuoZ.HuangW.MengX.AiG.TangG.et al. (2013). Mining of a streptothricin gene cluster from Streptomyces sp. TP-A0356 genome via heterologous expression. Sci. China Life Sci.56, 619–627. 10.1007/s11427-013-4504-2
49
LiQ.SongY.QinX.ZhangX.SunA.JuJ. (2015). Identification of the biosynthetic gene cluster for the anti-infective desotamides and production of a new analogue in a heterologous host. J. Nat. Prod.78, 944–948. 10.1021/acs.jnatprod.5b00009
50
LiT.DuY.CuiQ.ZhangJ.ZhuW.HongK.et al. (2013). Cloning, characterization and heterologous expression of the indolocarbazole biosynthetic gene cluster from marine-derived Streptomyces sanyensis FMA. Mar. Drugs11, 466–488. 10.3390/md11020466
51
LiuC.ZhangJ.LuC.ShenY. (2015). Heterologous expression of galbonolide biosynthetic genes in Streptomyces coelicolor. Antonie Van Leeuwenhoek107, 1359–1366. 10.1007/s10482-015-0415-5
52
LiuH.JiangH.HaltliB.KulowskiK.MuszynskaE.FengX.et al. (2009). Rapid cloning and heterologous expression of the meridamycin biosynthetic gene cluster using a versatile Escherichia coli-Streptomyces artificial chromosome vector, pSBAC. J. Nat. Prod.72, 389–395. 10.1021/np8006149
53
LopezP.HornungA.WelzelK.UnsinC.WohllebenW.WeberT.et al. (2010). Isolation of the lysolipin gene cluster of Streptomyces tendae Tu. Gene461, 5–14. 10.1016/j.gene.2010.03.016
54
MalcolmsonS. J.YoungT. S.RubyJ. G.Skewes-CoxP.WalshC. T. (2013). The posttranslational modification cascade to the thiopeptide berninamycin generates linear forms and altered macrocyclic scaffolds. Proc. Natl. Acad. Sci. U.S.A.110, 8483–8488. 10.1073/pnas.1307111110
55
MalpartidaF.NiemiJ.NavarreteR.HopwoodD. A. (1990). Cloning and expression in a heterologous host of the complete set of genes for biosynthesis of the Streptomyces coelicolor antibiotic undecylprodigiosin. Gene93, 91–99. 10.1016/0378-1119(90)90141-D
56
MantovaniS. M.MooreB. S. (2013). Flavin-linked oxidase catalyzes pyrrolizine formation of dichloropyrrole-containing polyketide extender unit in chlorizidine A. J. Am. Chem. Soc.135, 18032–18035. 10.1021/ja409520v
57
MartiT.HuZ.PohlN. L.ShahA. N.KhoslaC. (2000). Cloning, nucleotide sequence, and heterologous expression of the biosynthetic gene cluster for R1128, a non-steroidal estrogen receptor antagonist. Insights into an unusual priming mechanism. J. Biol. Chem.275, 33443–33448. 10.1074/jbc.M006766200
58
MartinezA.KolvekS. J.Tiong YipC. L.HopkeJ.BrownK. A.MacNeilI. A.et al. (2004). Genetically modified bacterial strains and novel bacterial artificial chromosome shuttle vectors for constructing environmental libraries and detecting heterologous natural products in multiple expression hosts. Appl. Environ. Microbiol.70, 2452–2463. 10.1128/AEM.70.4.2452-2463.2004
59
Martinez-BurgoY.Alvarez-AlvarezR.Perez-RedondoR.LirasP. (2014). Heterologous expression of Streptomyces clavuligerus ATCC 27064 cephamycin C gene cluster. J. Biotechnol.186, 21–29. 10.1016/j.jbiotec.2014.06.002
60
McClureR. A.GoeringA. W.JuK. S.BaccileJ. A.SchroederF. C.MetcalfW. W.et al. (2016). Elucidating the rimosamide-detoxin natural product families and their biosynthesis using metabolite/gene cluster correlations. ACS Chem. Biol.11, 3452–3460. 10.1021/acschembio.6b00779
61
MiaoV.Coeffet-LeGalM.BrianP.BrostR.PennJ.WhitingA.et al. (2005). Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology151(Pt 5), 1507–1523. 10.1099/mic.0.27757-0
62
MiyamotoK. T.KomatsuM.IkedaH. (2014). Discovery of gene cluster for mycosporine-like amino acid biosynthesis from Actinomycetales microorganisms and production of a novel mycosporine-like amino acid by heterologous expression. Appl. Environ. Microbiol.80, 5028–5036. 10.1128/AEM.00727-14
63
MontielD.KangH. S.ChangF. Y.Charlop-PowersZ.BradyS. F. (2015). Yeast homologous recombination-based promoter engineering for the activation of silent natural product biosynthetic gene clusters. Proc. Natl. Acad. Sci. U.S.A.112, 8953–8958. 10.1073/pnas.1507606112
64
MotamediH.HutchinsonC. R. (1987). Cloning and heterologous expression of a gene cluster for the biosynthesis of tetracenomycin C, the anthracycline antitumor antibiotic of Streptomyces glaucescens. Proc. Natl. Acad. Sci. U.S.A.84, 4445–4449. 10.1073/pnas.84.13.4445
65
NahH. J.WooM. W.ChoiS. S.KimE. S. (2015). Precise cloning and tandem integration of large polyketide biosynthetic gene cluster using Streptomyces artificial chromosome system. Microb. Cell Fact.14, 140. 10.1186/s12934-015-0325-2
66
NewmanD. J.CraggG. M. (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod.75, 311–335. 10.1021/np200906s
67
NiuG.LiL.WeiJ.TanH. (2013). Cloning, heterologous expression, and characterization of the gene cluster required for gougerotin biosynthesis. Chem. Biol.20, 34–44. 10.1016/j.chembiol.2012.10.017
68
OnakaH.TaniguchiS.IgarashiY.FurumaiT. (2002). Cloning of the staurosporine biosynthetic gene cluster from Streptomyces sp. TP-A0274 and its heterologous expression in Streptomyces lividans. J. Antibiot. (Tokyo)55, 1063–10671. 10.7164/antibiotics.55.1063
69
OoyaK.OgasawaraY.NoikeM.DairiT. (2015). Identification and analysis of the resorcinomycin biosynthetic gene cluster. Biosci. Biotechnol. Biochem.79, 1833–1837. 10.1080/09168451.2015.1050992
70
OtsukaM.IchinoseK.FujiiI.EbizukaY. (2004). Cloning, sequencing, and functional analysis of an iterative type I polyketide synthase gene cluster for biosynthesis of the antitumor chlorinated polyenone neocarzilin in “Streptomyces carzinostaticus.”Antimicrob. Agents Chemother.48, 3468–3476. 10.1128/AAC.48.9.3468-3476.2004
71
ParkO. K.ChoiH. Y.KimG. W.KimW. G. (2016). Generation of new complestatin analogues by heterologous expression of the complestatin biosynthetic gene cluster from Streptomyces chartreusis AN1542. Chembiochem17, 1725–1731. 10.1002/cbic.201600241
72
Robles-RegleroV.SantamartaI.Alvarez-AlvarezR.MartinJ. F.LirasP. (2013). Transcriptional analysis and proteomics of the holomycin gene cluster in overproducer mutants of Streptomyces clavuligerus. J. Biotechnol.163, 69–76. 10.1016/j.jbiotec.2012.09.017
73
RuiZ.HuangW.XuF.HanM.LiuX.LinS.et al. (2015). Sparsomycin biosynthesis highlights unusual module architecture and processing mechanism in non-ribosomal peptide synthetase. ACS Chem. Biol.10, 1765–1769. 10.1021/acschembio.5b00284
74
SalemS. M.KancharlaP.FlorovaG.GuptaS.LuW.ReynoldsK. A. (2014). Elucidation of final steps of the marineosins biosynthetic pathway through identification and characterization of the corresponding gene cluster. J. Am. Chem. Soc.136, 4565–4574. 10.1021/ja411544w
75
SanchezC.ButovichI. A.BranaA. F.RohrJ.MendezC.SalasJ. A. (2002). The biosynthetic gene cluster for the antitumor rebeccamycin: characterization and generation of indolocarbazole derivatives. Chem. Biol.9, 519–531. 10.1016/S1074-5521(02)00126-6
76
SaugarI.MolloyB.SanzE.Blanca SanchezM.Fernandez-LobatoM.JimenezA. (2016). Characterization of the biosynthetic gene cluster (ata) for the A201A aminonucleoside antibiotic from Saccharothrix mutabilis subsp. capreolus. J. Antibiot. (Tokyo). [Epub ahead of print]. 10.1038/ja.2016.123
77
ShahS.XueQ.TangL.CarneyJ. R.BetlachM.McDanielR. (2000). Cloning, characterization and heterologous expression of a polyketide synthase and P-450 oxidase involved in the biosynthesis of the antibiotic oleandomycin. J. Antibiot. (Tokyo)53, 502–508. 10.7164/antibiotics.53.502
78
ShizuyaH.BirrenB.KimU. J.MancinoV.SlepakT.TachiiriY.et al. (1992). Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. U.S.A.89, 8794–8797. 10.1073/pnas.89.18.8794
79
SinghD.SeoM. J.KwonH. J.RajkarnikarA.KimK. R.KimS. O.et al. (2006). Genetic localization and heterologous expression of validamycin biosynthetic gene cluster isolated from Streptomyces hygroscopicus var. limoneus KCCM 11405 (IFO 12704). Gene376, 13–23. 10.1016/j.gene.2005.12.035
80
SosioM.GiusinoF.CappellanoC.BossiE.PugliaA. M.DonadioS. (2000). Artificial chromosomes for antibiotic-producing actinomycetes. Nat. Biotechnol.18, 343–345. 10.1038/73810
81
SteffenskyM.MuhlenwegA.WangZ. X.LiS. M.HeideL. (2000). Identification of the novobiocin biosynthetic gene cluster of Streptomyces spheroides NCIB 11891. Antimicrob. Agents Chemother.44, 1214–1222. 10.1128/AAC.44.5.1214-1222.2000
82
SuC.ZhaoX.QiuR.TangL. (2015). Construction of the co-expression plasmids of fostriecin polyketide synthases and heterologous expression in Streptomyces. Pharm. Biol.53, 269–274. 10.3109/13880209.2014.914956
83
TangL.ShahS.ChungL.CarneyJ.KatzL.KhoslaC.et al. (2000). Cloning and heterologous expression of the epothilone gene cluster. Science287, 640–642. 10.1126/science.287.5453.640
84
ThanapipatsiriA.Gomez-EscribanoJ. P.SongL.BibbM. J.Al-BassamM.ChandraG.et al. (2016). Discovery of unusual biaryl polyketides by activation of a silent Streptomyces venezuelae biosynthetic gene cluster. Chembiochem17, 2189–2198. 10.1002/cbic.201600396
85
ThapaL. P.OhT. J.LeeH. C.LiouK.ParkJ. W.YoonY. J.et al. (2007). Heterologous expression of the kanamycin biosynthetic gene cluster (pSKC2) in Streptomyces venezuelae YJ003. Appl. Microbiol. Biotechnol.76, 1357–1364. 10.1007/s00253-007-1096-4
86
TorkkellS.KunnariT.PalmuK.MantsalaP.HakalaJ.YlihonkoK. (2001). The entire nogalamycin biosynthetic gene cluster of Streptomyces nogalater: characterization of a 20-kb DNA region and generation of hybrid structures. Mol. Genet. Genomics266, 276–288. 10.1007/s004380100554
87
VarshneyR. K.MirR. R.BhatiaS.ThudiM.HuY.AzamS.et al. (2014). Integrated physical, genetic and genome map of chickpea (Cicer arietinum L.). Funct. Integr. Genomics14, 59–73. 10.1007/s10142-014-0363-6
88
WaldmanA. J.PecherskyY.WangP.WangJ. X.BalskusE. P. (2015). The cremeomycin biosynthetic gene cluster encodes a pathway for diazo formation. Chembiochem16, 2172–2175. 10.1002/cbic.201500407
89
WangJ.YuY.TangK.LiuW.HeX.HuangX.et al. (2010). Identification and analysis of the biosynthetic gene cluster encoding the thiopeptide antibiotic cyclothiazomycin in Streptomyces hygroscopicus 10-22. Appl. Environ. Microbiol.76, 2335–2344. 10.1128/AEM.01790-09
90
WardS. L.HuZ.SchirmerA.ReidR.RevillW. P.ReevesC. D.et al. (2004). Chalcomycin biosynthesis gene cluster from Streptomyces bikiniensis: novel features of an unusual ketolide produced through expression of the chm polyketide synthase in Streptomyces fradiae. Antimicrob. Agents Chemother.48, 4703–4712. 10.1128/AAC.48.12.4703-4712.2004
91
WolpertM.HeideL.KammererB.GustB. (2008). Assembly and heterologous expression of the coumermycin A1 gene cluster and production of new derivatives by genetic engineering. Chembiochem9, 603–612. 10.1002/cbic.200700483
92
YamanakaK.ReynoldsK. A.KerstenR. D.RyanK. S.GonzalezD. J.NizetV.et al. (2014). Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A. Proc. Natl. Acad. Sci. U.S.A.111, 1957–1962. 10.1073/pnas.1319584111
93
YanX.ProbstK.LinnenbrinkA.ArnoldM.PaululatT.ZeeckA.et al. (2012). Cloning and heterologous expression of three type II PKS gene clusters from Streptomyces bottropensis. Chembiochem13, 224–230. 10.1002/cbic.201100574
94
YangC.HuangC.ZhangW.ZhuY.ZhangC. (2015). Heterologous expression of fluostatin gene cluster leads to a bioactive heterodimer. Org. Lett.17, 5324–5327. 10.1021/acs.orglett.5b02683
95
YinJ.HoffmannM.BianX.TuQ.YanF.XiaL.et al. (2015). Direct cloning and heterologous expression of the salinomycin biosynthetic gene cluster from Streptomyces albus DSM41398 in Streptomyces coelicolor A3(2). Sci. Rep.5:15081. 10.1038/srep15081
96
YinS.LiZ.WangX.WangH.JiaX.AiG.et al. (2016). Heterologous expression of oxytetracycline biosynthetic gene cluster in Streptomyces venezuelae WVR2006 to improve production level and to alter fermentation process. Appl. Microbiol. Biotechnol.100, 10563–10572. 10.1007/s00253-016-7873-1
97
YlihonkoK.HakalaJ.KunnariT.MantsalaP. (1996). Production of hybrid anthracycline antibiotics by heterologous expression of Streptomyces nogalater nogalamycin biosynthesis genes. Microbiology142(Pt 8), 1965–1972. 10.1099/13500872-142-8-1965
98
YoungT. S.WalshC. T. (2011). Identification of the thiazolyl peptide GE37468 gene cluster from Streptomyces ATCC 55365 and heterologous expression in Streptomyces lividans. Proc. Natl. Acad. Sci. U.S.A.108, 13053–13058. 10.1073/pnas.1110435108
99
ZaburannyiN.RabykM.OstashB.FedorenkoV.LuzhetskyyA. (2014). Insights into naturally minimised Streptomyces albus J1074 genome. BMC Genomics15:97. 10.1186/1471-2164-15-97
100
ZettlerJ.XiaH.BurkardN.KulikA.GrondS.HeideL.et al. (2014). New aminocoumarins from the rare actinomycete Catenulispora acidiphila DSM 44928: identification, structure elucidation, and heterologous production. Chembiochem15, 612–621. 10.1002/cbic.201300712
101
ZhangG.ZhangH.LiS.XiaoJ.ZhangG.ZhuY.et al. (2012). Characterization of the amicetin biosynthesis gene cluster from Streptomyces vinaceusdrappus NRRL 2363 implicates two alternative strategies for amide bond formation. Appl. Environ. Microbiol.78, 2393–2401. 10.1128/AEM.07185-11
102
ZhangY.HuangH.ChenQ.LuoM.SunA.SongY.et al. (2013). Identification of the grincamycin gene cluster unveils divergent roles for GcnQ in different hosts, tailoring the L-rhodinose moiety. Org. Lett.15, 3254–3257. 10.1021/ol401253p
103
ZhuY.FuP.LinQ.ZhangG.ZhangH.LiS.et al. (2012). Identification of caerulomycin A gene cluster implicates a tailoring amidohydrolase. Org. Lett.14, 2666–2669. 10.1021/ol300589r
Summary
Keywords
Streptomyces, natural product, biosynthetic gene cluster, heterologous expression, large-sized
Citation
Nah H-J, Pyeon H-R, Kang S-H, Choi S-S and Kim E-S (2017) Cloning and Heterologous Expression of a Large-sized Natural Product Biosynthetic Gene Cluster in Streptomyces Species. Front. Microbiol. 8:394. doi: 10.3389/fmicb.2017.00394
Received
31 December 2016
Accepted
24 February 2017
Published
15 March 2017
Volume
8 - 2017
Edited by
Wen-Jun Li, Sun Yat-sen University, China
Reviewed by
Shawn Chen, Revive Genomics Inc., USA; Jiangxin Wang, Shenzhen University, China
Updates
Copyright
© 2017 Nah, Pyeon, Kang, Choi and Kim.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Eung-Soo Kim eungsoo@inha.ac.kr
This article was submitted to Microbiotechnology, Ecotoxicology and Bioremediation, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.